Ecominas Corp.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Sep 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Revenue $796.0K $2.0K $389.3K $117.1K $1.2K $2.2K $15.9K $6.1K
Cost of Revenue — $0 $296 $190 $277 $139.2K $29.6K $73.0K
Gross Profit $796.0K $2.0K $389.0K $117.0K $928 $-137.0K $-13.7K $-66.9K
Gross Margin 100.0% 100.0% 99.9% 99.8% 77.0% -6,329.8% -86.4% -1,094.6%
Operating Expenses
Research & Development $29.9K $32.0K $37.8K $40.4K $69.1K $72.2K $141.3K $514.4K
SG&A Expense $798.3K $311.5K $557.6K $653.8K $738.5K $1.5M $1.2M $1.4M
Operating Income $-2.0M $-704.6K $-302.3K $-860.1K $-2.8M $-511.8K $-2.2M $-2.2M
Operating Margin -246.8% -35,837.4% -77.7% -734.2% -235,539.8% -23,641.3% -13,566.3% -35,911.6%
Interest Expense $5.1K $-196.9K $11.8K $4.0K $181.7K $-76.4K $1.2M $114.8K
Pretax Income $-2.1M $-796.5K $-487.1K $-1.2M $-2.9M $-525.0K $-3.4M $-2.2M
Income Tax Expense $527 — $355 $-110.9K — — $-999 $81.7K
Net Income $-2.0M $-731.6K $-394.8K $-942.3K $-2.8M $-383.3K $-3.3M $-2.3M
Net Margin -256.6% -37,211.3% -101.4% -804.4% -235,203.2% -17,705.7% -20,885.9% -37,052.1%
EPS (Basic) $-0.09 $-0.02 $-0.01 $-0.03 $-0.10 $0.08 $-0.27 $-0.23
EPS (Diluted) $-0.09 $-0.02 $-0.01 $-0.03 $-0.10 $0.08 $-0.27 $-0.23
Shares Outstanding (Basic) 23.3M 11.7M 37.2M 34.0M 29.2M 13.0M 12.2M 9.9M
Shares Outstanding (Diluted) 23.3M 11.7M 37.2M 34.0M 29.2M 13.0M 12.2M 9.9M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 7 Older →